The upcoming confirmation hearing for George Mason University law professor Neomi Rao, President Trump’s nominee to head the Office of Information and Regulatory Affairs, will likely showcase some ...

Peter Marks, director of Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research noted that “vaccination remains critical to public health and continued protection against ...

Global harmonization of CGT regulations could expedite access to innovative therapies by standardizing evaluation and regulatory processes. Only 20% of trials submitted to both the FDA and EMA had ...

President Trump has sought to take shortcuts in the otherwise lengthy regulatory process via executive order that could mark a notable expansion in presidential power. In recent weeks, Trump has ...

WASHINGTON, DC - MAY 12: (L-R) National Institutes of Health (NIH) Director Jay Bhattacharya, Administrator for the Centers for Medicare & Medicaid Services (CMS) Mehmet Oz, U.S. President Donald ...

In the changing field of technology, progress is driven by the pursuit of innovation which plays a vital role in enhancing patient care, prolonging lives, and improving overall healthcare outcomes.

This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund. Articles in this topic will offer timely ...

Navigating the complex landscape of drug approval presents significant regulatory challenges, requiring a delicate balance between fostering pharmaceutical innovation and ensuring patient safety. The ...

Section 1. Purpose. The United States is the most powerful economy in the world, but slow, complex, and burdensome American regulatory processes at every stage of a company’s development and operation ...

Section 1. Purpose. Abundant energy is a vital national- and economic-security interest. In conjunction with domestic fossil fuel production, nuclear energy can liberate America from dependence on ...